Exploring the treatment of COVID‐19 with Yinqiao powder based on network pharmacology

Coronavirus disease 2019 (COVID‐19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). In China, Yinqiao powder is widely used to prevent and treat COVID‐19 patients with Weifen syndrome. In this study, the screening and verification of active ingredients, target selection an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Phytother Res
Main Authors: Lin, Haixiong, Wang, Xiaotong, Liu, Minyi, Huang, Minling, Shen, Zhen, Feng, Junjie, Yang, Huijun, Li, Zige, Gao, Junyan, Ye, Xiaopeng
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd. 2021
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8013442/
https://ncbi.nlm.nih.gov/pubmed/33452734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ptr.7012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados